FRM
MYOV

Fox Run Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Fox Run Management’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,164
Closed -$183K – 961
2022
Q3 		$183K Buy
+10,164
New +$162K 0.07% 496
2022
Q1 		– Sell
-16,561
Closed -$258K – 768
2021
Q4 		$258K Buy
+16,561
New +$316K 0.15% 280

Other funds holding MYOV

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fox Run Management's MYOV Position: Q4 2022 in Review

Fox Run Management sold out of Myovant Sciences Ltd. (MYOV) in Q4 2022, closing a stake of 10,164 shares — an estimated $183K sold.

Fox Run Management first reported a position in MYOV in Q4 2021 and held it in 2 quarters. The position peaked at $258K in Q4 2021. 118 funds tracked by Wall St. Rank hold MYOV as of Q4 2022.

  • Fox Run Management reported no remaining Myovant Sciences Ltd. position as of Q4 2022 after selling out during the quarter.
  • Fox Run Management sold 10,164 Myovant Sciences Ltd. shares in Q4 2022, an estimated $183K.
  • Fox Run Management first reported a position in Myovant Sciences Ltd. in Q4 2021 and held it in 2 quarters.
  • Fox Run Management's Myovant Sciences Ltd. position peaked at $258K in Q4 2021.
  • 118 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2022.

Based on Fox Run Management's 13F filing for Q4 2022, filed 7 Feb 2023.